TR201103691A2 - Deferasirox dispersible tablet formulation. - Google Patents

Deferasirox dispersible tablet formulation.

Info

Publication number
TR201103691A2
TR201103691A2 TR2011/03691A TR201103691A TR201103691A2 TR 201103691 A2 TR201103691 A2 TR 201103691A2 TR 2011/03691 A TR2011/03691 A TR 2011/03691A TR 201103691 A TR201103691 A TR 201103691A TR 201103691 A2 TR201103691 A2 TR 201103691A2
Authority
TR
Turkey
Prior art keywords
tablet formulation
dispersible tablet
deferasirox
deferasirox dispersible
weight
Prior art date
Application number
TR2011/03691A
Other languages
Turkish (tr)
Inventor
Bulgur Abdullah
Kesgi̇n Di̇dehan
Original Assignee
Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. filed Critical Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş.
Priority to TR2011/03691A priority Critical patent/TR201103691A2/en
Publication of TR201103691A2 publication Critical patent/TR201103691A2/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, toplam tablet ağırlığına göre ağırlıkça % 40'tan fazla ve % 42'den az deferasiroks içeren dağılabilir tablet formülasyonu ile ilgilidir.@The present invention relates to a dispersible tablet formulation comprising more than 40% by weight and less than 42% by weight of deferasirox relative to the total tablet weight.

TR2011/03691A 2011-04-15 2011-04-15 Deferasirox dispersible tablet formulation. TR201103691A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2011/03691A TR201103691A2 (en) 2011-04-15 2011-04-15 Deferasirox dispersible tablet formulation.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2011/03691A TR201103691A2 (en) 2011-04-15 2011-04-15 Deferasirox dispersible tablet formulation.

Publications (1)

Publication Number Publication Date
TR201103691A2 true TR201103691A2 (en) 2011-08-22

Family

ID=44950495

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/03691A TR201103691A2 (en) 2011-04-15 2011-04-15 Deferasirox dispersible tablet formulation.

Country Status (1)

Country Link
TR (1) TR201103691A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2946771A1 (en) 2014-05-20 2015-11-25 Sanovel Ilac Sanayi ve Ticaret A.S. Water-dispersible tablet formulation comprising deferasirox
WO2019151967A2 (en) 2017-12-29 2019-08-08 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Water-dispersible tablet formulations comprising deferasirox

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2946771A1 (en) 2014-05-20 2015-11-25 Sanovel Ilac Sanayi ve Ticaret A.S. Water-dispersible tablet formulation comprising deferasirox
WO2019151967A2 (en) 2017-12-29 2019-08-08 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Water-dispersible tablet formulations comprising deferasirox

Similar Documents

Publication Publication Date Title
GT201200332A (en) SOLID COMPOSITIONS
UA108101C2 (en) N3-substituted N1-sulfonyl-5-fluoropyrimidinone derivatives
PH12014501273A1 (en) Intranasal dexmedetomidine compositions and methods of use thereof
NZ700595A (en) Pesticidal compositions and processes related thereto
UY34811A (en) COMPOUNDS AND COMPOSITIONS TO INHIBIT THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1
UA112086C2 (en) HERBICIDIC COMPOSITIONS INCLUDING CHLORACETAMIDES
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
MY173843A (en) Amidine substituted ?-lactam compounds, their preparation and use as antibacterial agents
MA37538A2 (en) Anti-Ly6 antibodies and immunoconjugates and methods of use
EA201691194A1 (en) RHC STIMULATORS
IT1404931B1 (en) OPHTHALMIC COMPOSITIONS FOR THE ADMINISTRATION OF LIPO-SOLUBLE ACTIVE PRINCIPLES.
AU2012228355A8 (en) N-(1,2,5-oxadiazol-3-yl)-, N-(tetrazol-5-yl)- and N-(triazol-5-yl)bicycloarylcarboxamides and their use as herbicides
MY173521A (en) Trpv4 antagonists
EA201391212A1 (en) NEW APPLICATIONS OF CHLORIDE IN AGROCHEMICAL PREPARATIONS
EA201101214A1 (en) POLYENE COMBINATION COMPOSITIONS
PH12014502512A1 (en) Topical pharmaceutical compositions comprising terbinafine and urea
UA112132C2 (en) MULTIPLE COFFEE PROCESSING
PH12015501054A1 (en) Pyridiyloxyalkyl carboxamides and use thereof as endoparasiticides and nematicides
TR201009394A2 (en) Improved montelukast formulations.
CA2872376A1 (en) 6-pyridone-2-carbamoyl-azoles and their use as herbicides
UA109804C2 (en) 2-methoxypyridine-4-yl derivatives
TR201103691A2 (en) Deferasirox dispersible tablet formulation.
WO2011156045A3 (en) Tablet formulation of ezatiostat
EA201690797A1 (en) NEW CONNECTIONS